Familial Cancer

Papers
(The H4-Index of Familial Cancer is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Laboratory variation in the grading of dysplasia of duodenal adenomas in familial adenomatous polyposis patients31
Cascade genetic testing: an underutilized pathway to equitable cancer care?22
Prevalence of cardiometabolic outcomes in women who underwent salpingo-oophorectomy to prevent hereditary breast and ovarian cancer: a meta-analysis21
Hereditary breast and ovarian cancer genetic testing in unselected patients: example of private supplementation of public healthcare service20
Colonoscopy surveillance in Lynch syndrome is burdensome and frequently delayed20
Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery17
Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study16
Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohort15
Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants14
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review13
Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review13
Misclassification of a frequent variant from PMS2CL pseudogene as a PMS2 loss of function variant in Brazilian patients12
Clinician perspectives on policy approaches to genetic risk disclosure in families12
0.63418221473694